Russell Investments Group
IPSC icon

Russell Investments Group’s Century Therapeutics IPSC Stock Holding History

Russell Investments Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,842
Closed -$14.9K – 3744
2024
Q2 		$14.9K Buy
5,842
+2,990
+105% +$9.45K ﹤0.01% 2995
2024
Q1 		$11.9K Hold
2,852
– – ﹤0.01% 2829
2023
Q4 		$9.47K Buy
2,852
+2,370
+492% +$4.32K ﹤0.01% 2830
2023
Q3 		$964 Sell
482
-1,893
-80% -$5.04K ﹤0.01% 3340
2023
Q2 		$7.5K Hold
2,375
– – ﹤0.01% 3024
2023
Q1 		$8.24K Hold
2,375
– – ﹤0.01% 2909
2022
Q4 		$12.2K Hold
2,375
– – ﹤0.01% 2837
2022
Q3 		$23K Sell
2,375
-933
-28% -$9.83K ﹤0.01% 2801
2022
Q2 		$27K Buy
+3,308
New +$32.4K ﹤0.01% 2774

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Russell Investments Group's IPSC Position: Q3 2024 in Review

Russell Investments Group sold out of Century Therapeutics (IPSC) in Q3 2024, closing a stake of 5,842 shares — an estimated $14.9K sold.

Russell Investments Group first reported a position in IPSC in Q2 2022 and held it in 9 quarters. The position peaked at $27K in Q2 2022. 67 funds tracked by Wall St. Rank hold IPSC as of Q3 2024.

  • Russell Investments Group reported no remaining Century Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 5,842 Century Therapeutics shares in Q3 2024, an estimated $14.9K.
  • Russell Investments Group first reported a position in Century Therapeutics in Q2 2022 and held it in 9 quarters.
  • Russell Investments Group's Century Therapeutics position peaked at $27K in Q2 2022.
  • 67 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.